Last updated: 2026-09-06 05:12:20. Prices reflect the latest closing data and will resume updating on the next trading day. Stock price data is sourced from Massive.
DataMeds AI, Inc. (MEDS) operates in the WHOLESALE-DRUGS, PROPRIETARIES & DRUGGISTS' SUNDRIES sector and is listed on NASDAQ. The stock is currently priced at $0.92, with a market capitalisation of $3.15M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $0.82 to $3.88. This page covers its latest market performance, valuation, price trends and company information.
$3.15M | |
$0.98 | |
$504.00 | |
$0.82 | |
$0.96 | |
307.10K | |
-- | |
-- | |
$3.88 | |
$0.82 | |
-- | |
-- |
DataMeds AI, Inc. (MEDS) last closed at $0.96 as of 2026-09-04 23:48:00, unchanged from the previous close of $0.96.
During the latest regular trading session, MEDS traded between $0.82 and $504.00, with a volume of 307.10K shares. The closing price was near the lower end and near the lower end of its 52-week range.
Over the past seven days, DataMeds AI, Inc. (MEDS) moved from $0.88 to $0.92, representing a gain of 4.56% ($0.04).
The stock traded between $0.92 and $1.02 during the period. The latest price is near the lower end of the 7-day range, indicating moderate upward.
The average daily volume was 1.27 million shares, up versus the previous seven-day period, indicating higher trading activity.
Position in Range: 3.1%
MEDS is currently trading at $0.92, placing it 3.1% of the way from its 52-week low of $0.82 to its 52-week high of $3.88. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
DataMEDS AI Inc is a healthcare technology and pharmaceutical logistics company. The group simplifies the logistics of prescription fulfillment from the manufacturer and provider to the patient. Its solutions provide a single, integrated platform for pharmacies, wholesale distribution, and a fulfillment network focused on Independent Pharmacies and Specialty Lite medications.
| Industry | WHOLESALE-DRUGS, PROPRIETARIES & DRUGGISTS' SUNDRIES |
| Exchange | NASDAQ |
| Company Website |
Eligible investors can buy real shares of DataMeds AI, Inc. (MEDS) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.